TRIM50 inhibits glycolysis and the malignant progression of gastric cancer by ubiquitinating PGK1

Abstract excerpt

. Remarkably, we found that TRIM50 was downregulated in GC tissues, associated with malignant progression and poor patient survival. Functionally, overexpression of TRIM50 suppressed GC cell proliferation and indirectly mitigated the invasion and migration of GC cells by inhibiting the M2 polarization of tumor-associated macrophages (TAMs). Mechanistically, TRIM50 inhibited the glycolytic pathway by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to interferon and immune responses
• Share to Peptidase Inhibition and Analysis
• Share to Ubiquitin and proteasome pathways